You just read:

Adastra Pharmaceuticals Announces FDA and EMA Orphan Drug Designation Has Been Granted for Zotiraciclib in the Treatment of Glioma

News provided by

Adastra Pharmaceuticals, Inc.

Dec 04, 2019, 08:02 ET